JPMorgan Chase & Co’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28K | Sell |
2,068
-26,067
| -93% | -$28.7K | ﹤0.01% | 5636 |
|
|
2025
Q1 | $27.6K | Buy |
28,135
+1,059
| +4% | +$1.04K | ﹤0.01% | 5191 |
|
|
2024
Q4 | $42.2K | Buy |
27,076
+5,099
| +23% | +$7.96K | ﹤0.01% | 5067 |
|
|
2024
Q3 | $80.7K | Buy |
21,977
+665
| +3% | +$2.44K | ﹤0.01% | 4807 |
|
|
2024
Q2 | $70.5K | Buy |
21,312
+20,812
| +4,162% | +$68.9K | ﹤0.01% | 4768 |
|
|
2024
Q1 | $2.13K | Hold |
500
| – | – | ﹤0.01% | 5560 |
|
|
2023
Q4 | $900 | Hold |
500
| – | – | ﹤0.01% | 5810 |
|
|
2023
Q3 | $995 | Sell |
500
-3,813
| -88% | -$7.59K | ﹤0.01% | 5687 |
|
|
2023
Q2 | $11K | Sell |
4,313
-720
| -14% | -$1.84K | ﹤0.01% | 5152 |
|
|
2023
Q1 | $20K | Buy |
+5,033
| New | +$20K | ﹤0.01% | 5141 |
|
|
2022
Q2 | – | Sell |
-4,986
| Closed | -$20K | – | 5842 |
|
|
2022
Q1 | $20K | Sell |
4,986
-6,783
| -58% | -$27.2K | ﹤0.01% | 5265 |
|
|
2021
Q4 | $129K | Buy |
+11,769
| New | +$129K | ﹤0.01% | 4729 |
|